CLDN1 and cancer: Reports documenting that SRGN promotes cancer cell aggressiveness and metastasis through several signaling pathways, including CD44/NF-κB/CLDN1 axis, HIF-1α/SRGN axis, and SRGN/TGFβ2 axis, may further support our observations presented here28,38,39.